These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 162885)

  • 41. Conformational transition accompanying the binding of Ca2+ to the protein activator of 3',5'-cyclic adenosine monophosphate phosphodiesterase.
    Klee CB
    Biochemistry; 1977 Mar; 16(5):1017-24. PubMed ID: 14663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A brain protein and its effect on the Ca2+-and protein modulator-activated cyclic nucleotide phosphodiesterase.
    Wang JH; Desai R
    Biochem Biophys Res Commun; 1976 Oct; 72(3):926-32. PubMed ID: 186066
    [No Abstract]   [Full Text] [Related]  

  • 43. Preparation and characterization of multiple forms of cyclic nucleotide phosphodiesterase from liver.
    Terasaki WL; Russell TR; Appleman MM
    Methods Enzymol; 1974; 38():257-9. PubMed ID: 4375757
    [No Abstract]   [Full Text] [Related]  

  • 44. The distribution of the Ca++-dependent protein activator of cyclic nucleotide phosphodiesterase in invertebrates.
    Waisman D; Stevens FC; Wang JH
    Biochem Biophys Res Commun; 1975 Aug; 65(3):975-82. PubMed ID: 168896
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclic AMP phosphodiesterase of Escherichia coli.
    Nielsen LD; Rickenberg HV
    Methods Enzymol; 1974; 38():249-56. PubMed ID: 4375756
    [No Abstract]   [Full Text] [Related]  

  • 46. Purification and properties of cyclic nucleotide phosphodiesterase from Dictyostelium discoideum (extracellular).
    Chassy BM; Porter EV
    Methods Enzymol; 1974; 38():244-8. PubMed ID: 4375755
    [No Abstract]   [Full Text] [Related]  

  • 47. Regulation of brain phosphodiesterase activity: Ca++ plus Mg++ -dependent phosphodiesterase and its activating factor from rat brain.
    Kakiuchi S; Yamazaki R; Teshima Y
    Adv Cyclic Nucleotide Res; 1972; 1():455-77. PubMed ID: 4353182
    [No Abstract]   [Full Text] [Related]  

  • 48. An effect of age on the phosphodiesterase activator protein of rat cerebral cortex. A brief note.
    Zimmerman ID; Berg AP
    Mech Ageing Dev; 1977; 6(1):67-71. PubMed ID: 189141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation, characterization, and properties of a novel triple-modified derivative of the Ca2+ -dependent protein modulator.
    Walsh M; Stevens FC
    Can J Biochem; 1978 Jun; 56(6):420-9. PubMed ID: 208726
    [No Abstract]   [Full Text] [Related]  

  • 50. Activity of tubercidin-, toyocomycin-, and sangivamycin-3',5'-cyclic phosphates and related compounds with some enzymes of adenosine-3',5'-cyclic phosphate metabolism.
    Miller JP; Boswell KH; Muneyama K; Tolman RL; Scholten MB; Robins RK; Simon LN; Shuman DA
    Biochem Biophys Res Commun; 1973 Dec; 55(3):843-9. PubMed ID: 4357434
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclic nucleotide phosphodiesterase from a particulate fraction of rat brain. Evidence for an activator deficient form.
    Lindl T; Chapman G
    Biochem Biophys Res Commun; 1976 Aug; 71(4):1273-82. PubMed ID: 9937
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of zinc chloride on the hydrolysis of cyclic GMP and cyclic AMP by the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1978 Jan; 522(1):151-60. PubMed ID: 202321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic nucleotide phosphodiesterase in silkworm. Separation and characterization of multiple forms of the enzyme.
    Morishima I
    Biochim Biophys Acta; 1975 May; 391(1):75-83. PubMed ID: 237560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
    Levin RM; Weiss B
    J Pharmacol Exp Ther; 1979 Mar; 208(3):454-9. PubMed ID: 34709
    [No Abstract]   [Full Text] [Related]  

  • 55. Cyclic 3',5'-nucleotide phosphodiesterase. Evidence for and properties of a protein activator.
    Cheung WY
    J Biol Chem; 1971 May; 246(9):2859-69. PubMed ID: 4324340
    [No Abstract]   [Full Text] [Related]  

  • 56. Development of cyclic AMP metabolism in rat liver. A correlative study of tissue levels of cyclic AMP, accumulation of cyclic AMP in slices, adenylate cyclase activity and cyclic nucleotide phosphodiesterase activity.
    Christoffersen T; Morland J; Osnes JB; Oye I
    Biochim Biophys Acta; 1973 Jul; 313(2):338-49. PubMed ID: 4354955
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
    Hidaka H; Asano T; Shimamoto T
    Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effects of Ca 2+ and Mg 2+ on the adenyl cyclase of beef brain.
    Bradham LS
    Biochim Biophys Acta; 1972 Aug; 276(2):434-43. PubMed ID: 4341589
    [No Abstract]   [Full Text] [Related]  

  • 59. Calcium-regulated phosphodiesterase in bovine parathyroid cells.
    Brown EM
    Endocrinology; 1980 Dec; 107(6):1998-2003. PubMed ID: 6253285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.
    Weiss B
    Adv Cyclic Nucleotide Res; 1975; 5():195-211. PubMed ID: 165666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.